Total Participants
196,864
Mean Age
48 years
Metabolic Syndrome Cases
58,231
MS Prevalence Rate
29.6%
Male Participants
72,046
Female Participants
124,818
High BP Cases
61,175
Abdominal Obesity Cases
89,665
Metabolic Syndrome Prevalence by Age Group
Metabolic Syndrome by Gender
MS Components Distribution by Gender
Age Distribution by MS Status
Metabolic Syndrome Biomarkers Correlation Matrix
Distribution of Metabolic Syndrome Score
Waist Circumference Distribution by Gender and Age
Blood Pressure Distribution by MS Status
Metabolic Syndrome Biomarkers Summary by Gender
| Biomarker | N | Overall N = 196,8641 |
Gender
|
p-value2 | |
|---|---|---|---|---|---|
| Female N = 124,8181 |
Male N = 72,0461 |
||||
| Age (years) | 196,864 | <0.001 | |||
| Mean ± SD | 48.0 ± 12.7 | 48.1 ± 12.5 | 47.8 ± 13.1 | ||
| Median (Q1, Q3) | 48.0 (38.0, 58.0) | 49.0 (38.0, 58.0) | 48.0 (37.0, 59.0) | ||
| Waist Circumference (cm) | 196,864 | <0.001 | |||
| Mean ± SD | 83.1 ± 10.7 | 80.3 ± 10.2 | 87.9 ± 9.9 | ||
| Median (Q1, Q3) | 82.5 (75.5, 90.0) | 79.0 (73.0, 86.0) | 87.5 (81.5, 94.0) | ||
| Systolic BP (mmHg) | 196,864 | <0.001 | |||
| Mean ± SD | 120.3 ± 18.6 | 116.8 ± 18.5 | 126.3 ± 17.1 | ||
| Median (Q1, Q3) | 118.0 (107.0, 131.0) | 114.0 (104.0, 127.0) | 124.0 (114.0, 136.0) | ||
| Diastolic BP (mmHg) | 196,864 | <0.001 | |||
| Mean ± SD | 74.1 ± 11.3 | 71.6 ± 10.7 | 78.3 ± 11.1 | ||
| Median (Q1, Q3) | 73.0 (66.0, 81.0) | 70.0 (64.0, 78.0) | 78.0 (70.0, 85.0) | ||
| Fasting Glucose (mg/dL) | 196,705 | <0.001 | |||
| Mean ± SD | 95.7 ± 20.2 | 93.8 ± 18.4 | 98.9 ± 22.5 | ||
| Median (Q1, Q3) | 92.0 (87.0, 98.0) | 90.0 (86.0, 96.0) | 94.0 (89.0, 100.0) | ||
| Triglycerides (mg/dL) | 196,703 | <0.001 | |||
| Mean ± SD | 113.5 ± 95.1 | 100.8 ± 72.9 | 135.6 ± 121.4 | ||
| Median (Q1, Q3) | 90.0 (63.0, 135.0) | 82.0 (59.0, 120.0) | 108.0 (74.0, 160.0) | ||
| HDL Cholesterol (mg/dL) | 196,704 | <0.001 | |||
| Mean ± SD | 55.5 ± 13.8 | 59.4 ± 13.6 | 48.8 ± 11.4 | ||
| Median (Q1, Q3) | 54.0 (45.0, 64.0) | 58.0 (50.0, 68.0) | 47.0 (41.0, 55.0) | ||
| BMI (kg/m²) | 196,833 | <0.001 | |||
| Mean ± SD | 24.2 ± 3.9 | 23.5 ± 3.9 | 25.4 ± 3.7 | ||
| Median (Q1, Q3) | 23.7 (21.5, 26.4) | 22.9 (20.8, 25.6) | 25.0 (22.9, 27.4) | ||
| Metabolic Syndrome | 196,864 | 58,231 (29.6%) | 34,374 (27.5%) | 23,857 (33.1%) | <0.001 |
| 1 n (%) | |||||
| 2 Welch Two Sample t-test; Pearson’s Chi-squared test | |||||
Metabolic Syndrome Components by Age Group
| age_group | N | Abdominal Obesity (%) | High Blood Pressure (%) | High Glucose (%) | High Triglycerides (%) | Low HDL (%) | MS Prevalence (%) |
|---|---|---|---|---|---|---|---|
| <30 | 16606 | 26.1 | 11.8 | 5.7 | 86.3 | 15.4 | 11.6 |
| 30-39 | 45815 | 40.5 | 16.7 | 9.2 | 80.8 | 22.7 | 19.7 |
| 40-49 | 44850 | 45.5 | 26.4 | 16.9 | 77.1 | 24.7 | 27.0 |
| 50-59 | 51112 | 49.5 | 37.3 | 27.2 | 72.6 | 24.2 | 34.7 |
| 60-69 | 35954 | 54.5 | 52.9 | 36.3 | 71.5 | 24.3 | 44.7 |
| ≥70 | 2527 | 58.8 | 63.6 | 43.9 | 71.8 | 22.3 | 53.3 |